## Review setup
- **Input scope** Full manuscript text (abstract, introduction, methods, results, discussion) as provided
- **Assessment boundary** Scientific validity, methodological soundness, reproducibility, and claims as supported by the provided evidence
- **Shared manuscript claim summary** The authors propose DPB-NBFnet, a graph neural network based on Neural Bellman-Ford networks, to predict DNA-protein binding. They claim state-of-the-art performance on 100 ENCODE datasets compared to baseline link prediction methods, and report high accuracy, precision, and recall.
- **Visible evidence base** Abstract, introduction, related work, methodology description, experimental setup, results tables referenced (Tables 1-3), discussion, and conclusion. No actual data tables, figures, or supplementary materials are included in the provided text.
- **Missing materials affecting confidence** Actual results tables (Tables 1-3), figure 1 (workflow diagram), algorithm pseudocode (Algorithm 1), dataset details, hyperparameter settings, baseline implementation details, and any statistical significance testing. Without these, quantitative claims cannot be independently verified.

## Reviewer
- **Overall assessment** The manuscript presents a reasonable application of an existing graph neural network architecture (NBFnet) to a biologically relevant prediction problem. The motivation is clear and the problem is of interest. However, the manuscript has substantial gaps in experimental reporting, lacks critical comparisons and ablations, and makes claims of superiority that are not adequately supported by the evidence presented. The methodological novelty is limited, as NBFnet is a published method and the contribution here appears to be primarily an application with minor modifications. The writing quality is acceptable but the scientific rigor is insufficient for the claims made.
- **Who would be interested in the results, and why** Computational biologists working on DNA-protein interaction prediction, researchers in graph neural network applications to biological problems, and those interested in link prediction methods for genomic data. The work may also be of interest to researchers developing deep learning methods for regulatory genomics.
- **Major strengths** 
  - Clear problem motivation with practical relevance
  - Application of a recent, well-performing GNN architecture to a new domain
  - Exploration of architectural choices (neural functions, layer count)
  - Use of multiple evaluation metrics
- **Major Concerns**
  - **Concern ID** R1-M1
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Evidence sufficiency
  - **Claim pointer** The authors claim "state-of-the-art performance" and report specific numerical results (93.7% precision, 92.6% recall, 95.2% accuracy) in Section 4.2.
  - **Evidence pointer** Section 4.2, Table 1 (not provided in the manuscript text)
  - **Concern** The actual results tables are not included in the provided material. Without the numerical data, baseline comparisons, and variance measures, the central performance claims cannot be evaluated. The claim of "state-of-the-art" requires comparison against a comprehensive set of baselines with statistical significance testing, none of which is visible.
  - **Why it matters** The core contribution of the paper is the claimed performance improvement. Without the actual data, the scientific case is not established.
  - **Resolution test** Provide the full results tables with all baseline performances, standard deviations, and statistical significance tests (e.g., paired t-tests or Wilcoxon signed-rank tests) across the 100 datasets.

  - **Concern ID** R1-M2
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Reproducibility
  - **Claim pointer** The methodology section describes the model architecture but lacks critical implementation details.
  - **Evidence pointer** Section 3 (Methodology), Section 4.1 (Experiment setup)
  - **Concern** The manuscript does not provide sufficient details for reproduction: no hyperparameter values (learning rate, batch size, epochs, optimizer), no train/validation/test split details beyond "four-fold cross-validation", no description of how the graph is constructed from sequence data (node features, edge features), no details on the IND, MES, and AGG function implementations, and no information on the SortPooling parameter K. The data representation section is vague about how sequences are converted to graph structures.
  - **Why it matters** Reproducibility is a fundamental requirement for scientific publication. Without these details, other researchers cannot replicate or build upon the work.
  - **Resolution test** Provide complete implementation details, including all hyperparameters, graph construction methodology, and code availability.

  - **Concern ID** R1-M3
  - **Severity** Major
  - **Blocking** No
  - **Axis** Novelty and contribution
  - **Claim pointer** The authors state "we propose a novel GNN method" and "we put the latest Neural Bellman-Ford neural networks (NBFnets) into use."
  - **Evidence pointer** Section 1 (Introduction), Section 3 (Methodology)
  - **Concern** The novelty appears limited to applying an existing architecture (NBFnet) to a new problem domain. The modifications described (adding SortPooling and AlphaMEX) are not deeply motivated or compared against alternatives. The paper does not clearly articulate what new scientific or methodological insight is provided beyond "NBFnet works for this problem too."
  - **Why it matters** For a methods-focused paper, the novelty must be clearly articulated and justified. If the contribution is purely applicational, the biological insights or practical advantages must be more thoroughly demonstrated.
  - **Resolution test** Clearly articulate the novel contributions, provide ablation studies showing the benefit of each component, and discuss what new understanding is gained.

  - **Concern ID** R1-M4
  - **Severity** Major
  - **Blocking** No
  - **Axis** Baseline and comparison adequacy
  - **Claim pointer** The authors claim superiority over "other GNN models for the link prediction problem" and compare against Katz index, node2vec, VG AE, DRUM, and SEAL.
  - **Evidence pointer** Section 4.2, Table 1 (not provided)
  - **Concern** The baseline selection is reasonable but the comparison is incomplete. No non-GNN deep learning methods for DNA-protein binding (e.g., DeepBind, DeepRAM) are included. The comparison is against general link prediction methods, not against domain-specific state-of-the-art methods for DNA-protein binding prediction. Additionally, the authors do not report whether the baselines were tuned fairly or if the same data splits were used.
  - **Why it matters** A fair and comprehensive comparison is essential to support the claim of superiority. Without domain-specific baselines, the practical value of the method is unclear.
  - **Resolution test** Include domain-specific baselines for DNA-protein binding prediction, report hyperparameter tuning for all methods, and ensure identical data splits and evaluation protocols.

  - **Concern ID** R1-M5
  - **Severity** Major
  - **Blocking** No
  - **Axis** Statistical rigor
  - **Claim pointer** The authors report average metrics across 100 datasets but do not report variance or statistical significance.
  - **Evidence pointer** Section 4.2, Section 3.7 (Measurements and evaluation)
  - **Concern** The manuscript reports mean values of precision, recall, accuracy, MCC, and AUROC but does not report standard deviations, confidence intervals, or any statistical comparison between methods. Given the variability expected across 100 diverse datasets, this is a significant omission.
  - **Why it matters** Without measures of variance and statistical testing, the reader cannot assess whether observed differences are meaningful or due to chance.
  - **Resolution test** Report standard deviations or confidence intervals for all metrics, and perform appropriate statistical tests comparing DPB-NBFnet against each baseline.

  - **Concern ID** R1-M6
  - **Severity** Major
  - **Blocking** No
  - **Axis** Data and dataset description
  - **Claim pointer** The authors state they used "100 datasets from ENCODE datasets" and that positive samples are "DNA sequences that were experimentally verified and confirmed to bind to this protein."
  - **Evidence pointer** Section 3.1 (Data representations), Section 4.1 (Experiment setup)
  - **Concern** The dataset description is insufficient. No information is provided on which specific ENCODE datasets were used, how they were selected, the size of each dataset, the sequence lengths, the number of positive and negative samples, or how negative samples were generated beyond "corrupting one of the entities." The random selection of 100 datasets from over 500,000 raises questions about representativeness and potential bias.
  - **Why it matters** Dataset characteristics significantly affect model performance and generalizability. Without this information, the results cannot be properly interpreted or compared with other work.
  - **Resolution test** Provide a detailed description of the datasets, including accession numbers, sample counts, sequence properties, and the negative sample generation procedure.

- **Minor Comments**
  - **Concern ID** R1-m1
  - **Severity** Minor
  - **Axis** Clarity
  - **Affected element** Section 2.3, Equations 1-2
  - **Evidence pointer** Section 2.3
  - **Issue** The notation is confusing. The authors use both "Puv" and "P|Puv|" inconsistently, and the subscript "i" in "P i" is not clearly defined. The relationship between the path formulation and the actual implementation is not made clear.
  - **Required correction** Clarify the notation, define all symbols precisely, and explain how the path formulation relates to the neural implementation.

  - **Concern ID** R1-m2
  - **Severity** Minor
  - **Axis** Consistency
  - **Affected element** Section 3.7, Equations 9-12
  - **Evidence pointer** Section 3.7
  - **Issue** The authors define PR (precision) and RE (recall) but use different abbreviations in the text (AP for average precision, AR for average recall). The relationship between the per-sample metrics and the averaged metrics is unclear.
  - **Required correction** Use consistent terminology and clarify whether the reported metrics are macro-averaged or micro-averaged across datasets.

  - **Concern ID** R1-m3
  - **Severity** Minor
  - **Axis** Accuracy of claims
  - **Affected element** Section 5.1
  - **Evidence pointer** Section 5.1
  - **Issue** The authors state "our DPB-NBFnet framework was able to achieve a prediction accuracy of 97.2%" in the discussion, but Section 4.2 reports 95.2% accuracy. This discrepancy is not explained.
  - **Required correction** Reconcile the accuracy values reported in different sections or clarify the context of each number.

  - **Concern ID** R1-m4
  - **Severity** Minor
  - **Axis** Completeness
  - **Affected element** Section 4.3
  - **Evidence pointer** Section 4.3
  - **Issue** The exploration of neural functions and layer count is presented only as tables without discussion of the patterns observed or the implications for model design.
  - **Required correction** Add interpretation of the results in Tables 2 and 3, discussing why certain configurations perform better and what this suggests about the problem structure.

  - **Concern ID** R1-m5
  - **Severity** Minor
  - **Axis** Writing quality
  - **Affected element** Throughout
  - **Evidence pointer** Throughout
  - **Issue** There are several typographical and grammatical errors (e.g., "LTSM" should be "LSTM", "VG AE" in the review text, inconsistent use of "DNA-protein binding" vs "DNA-protein bindings"). Some sentences are awkwardly phrased.
  - **Required correction** Careful proofreading and language editing.

  - **Concern ID** R1-m6
  - **Severity** Minor
  - **Axis** Related work
  - **Affected element** Section 2
  - **Evidence pointer** Section 2
  - **Issue** The related work section is brief and does not adequately cover recent deep learning methods for DNA-protein binding prediction, particularly those using convolutional or transformer architectures.
  - **Required correction** Expand the related work to include a more comprehensive review of existing methods and clearly position the contribution relative to them.

## Risk / unsupported claims
- The claim of "state-of-the-art performance" is unsupported without the actual results tables and comprehensive baseline comparisons.
- The reported accuracy discrepancy between Section 4.2 (95.2%) and Section 5.1 (97.2%) is unexplained and undermines confidence in the reported numbers.
- The claim that the method "could be applied into predictions of DNA-protein binding on real datasets" is not supported by any demonstration on independent or held-out real-world data beyond the ENCODE datasets used for evaluation.
- The statement that "the final accuracy and time consumption of our DNA-NBFnet framework for prediction of DNA-protein binding have been shown to be superior" is not verifiable from the provided material.
- The claim that "paths no longer than six are enough for a link prediction problem" is speculative and not supported by any analysis or theoretical justification.
- The assertion that the method "will also inspire other computational biological models" is speculative and not a scientific claim.
- The data availability statement mentions supplementary material, but none is provided in the manuscript text, making it impossible to verify any of the experimental results.